» Articles » PMID: 25808502

Redefining Phenotypes Associated with Mitochondrial DNA Single Deletion

Abstract

Progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson syndrome are the three sporadic clinical syndromes classically associated with single large-scale deletions of mitochondrial DNA (mtDNA). PEO plus is a term frequently utilized in the clinical setting to identify patients with PEO and some degree of multisystem involvement, but a precise definition is not available. The purpose of the present study is to better define the clinical phenotypes associated with a single mtDNA deletion, by a retrospective study on a large cohort of 228 patients from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". In our database, single deletions account for about a third of all patients with mtDNA-related disease, more than previously recognized. We elaborated new criteria for the definition of PEO and "KSS spectrum" (a category of which classic KSS represents the most severe extreme). The criteria for "KSS spectrum" include the resulting multisystem clinical features associated with the KSS features, and which therefore can predict their presence or subsequent development. With the new criteria, we were able to classify nearly all our single-deletion patients: 64.5% PEO, 31.6% KSS spectrum (including classic KSS 6.6%) and 2.6% Pearson syndrome. The deletion length was greater in KSS spectrum than in PEO, whereas heteroplasmy was inversely related with age at onset. We believe that the new phenotype definitions implemented here may contribute to a more homogeneous patient categorization, which will be useful in future cohort studies of natural history and clinical trials.

Citing Articles

Clinical manifestations and pathogenesis of mitochondrial dysfunction in short stature.

Jiang Y, Wan Z, Zhang X, Du H, Yang Y, Pan H World J Pediatr. 2025; .

PMID: 40009295 DOI: 10.1007/s12519-025-00881-y.


A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment.

Huang A, Xue H, Xie T, Xiang L, Chen Z, Ma A J Transl Med. 2025; 23(1):70.

PMID: 39815317 PMC: 11734335. DOI: 10.1186/s12967-025-06077-2.


Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.


A platform to map the mind-mitochondria connection and the hallmarks of psychobiology: the MiSBIE study.

Kelly C, Trumpff C, Acosta C, Assuras S, Baker J, Basarrate S Trends Endocrinol Metab. 2024; 35(10):884-901.

PMID: 39389809 PMC: 11555495. DOI: 10.1016/j.tem.2024.08.006.


Mechanisms and pathologies of human mitochondrial DNA replication and deletion formation.

Bernardino Gomes T, Vincent A, Menger K, Stewart J, Nicholls T Biochem J. 2024; 481(11):683-715.

PMID: 38804971 PMC: 11346376. DOI: 10.1042/BCJ20230262.


References
1.
Lopez-Gallardo E, Lopez-Perez M, Montoya J, Ruiz-Pesini E . CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion. 2009; 9(5):314-7. DOI: 10.1016/j.mito.2009.04.005. View

2.
DiMauro S, Schon E . Mitochondrial respiratory-chain diseases. N Engl J Med. 2003; 348(26):2656-68. DOI: 10.1056/NEJMra022567. View

3.
Horga A, Pitceathly R, Blake J, Woodward C, Zapater P, Fratter C . Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia. Brain. 2014; 137(Pt 12):3200-12. PMC: 4240292. DOI: 10.1093/brain/awu279. View

4.
Magalhaes P, Sjo O, Norby S . Ocular myopathy and mitochondrial DNA deletion. A presentation of seven identified Danish patients. Acta Ophthalmol Scand Suppl. 1996; (219):29-32. View

5.
Schroder R, Vielhaber S, Wiedemann F, Kornblum C, Papassotiropoulos A, Broich P . New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropathol Exp Neurol. 2000; 59(5):353-60. DOI: 10.1093/jnen/59.5.353. View